MRNA dividend yield: 4.00%. HTGC dividend yield: 10.22%. MRNA is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in MRNA shares. Hercules Capital specializes in lending to venture-backed technology and life sciences companies. This unique focus allows it to capture higher yields than traditional BDCs. Strong origination network with leading VC firms. HTGC pays regular plus supplemental dividends, making total yield among the highest in BDC space.
MRNA is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in MRNA shares.
Hercules Capital specializes in lending to venture-backed technology and life sciences companies. This unique focus allows it to capture higher yields than traditional BDCs. Strong origination network with leading VC firms. HTGC pays regular plus supplemental dividends, making total yield among the highest in BDC space.
Is MRNA or HTGC better for dividend income in 2026?
MRNA currently offers a 4.00% yield (2.00/share/year) while HTGC offers 10.22% (1.88/share/year). HTGC provides higher current income. However, MRNA has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRNA vs HTGC earn per year?
With $10,000 invested today: MRNA pays approximately $400/year. HTGC pays approximately $1022/year. With DRIP reinvestment over 10 years, these grow to $899/year (MRNA) and $3,064/year (HTGC).
Does MRNA or HTGC pay monthly dividends?
MRNA pays quarterly dividends. HTGC pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRNA vs HTGC comparison by email
Save your analysis + get weekly dividend insights. Free forever.